Editorial by Susan Marlin, President & CEO, Clinical Trials Ontario
Imagine a future where we can tailor disease prevention, diagnosis and treatment to individual patients, based on a deep understanding of their genetic and molecular profile. That’s the dream of personalized medicine. And while it’s still in its infancy, clinical trials are getting underway to make this innovative approach to healthcare a reality for Canadians.
The outcomes of personalized medicine trials have the potential to change how we think about and deliver healthcare. And trial participants play a vital role in making those trials possible.